EUVIMEDEUVIMED entdecken
Crossref

Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease

Yang Li, Lijun Guo, Xiya Yu, Changgeng Peng

Ageing and Neurodegenerative Diseases · 06.05.2026 · 6 (2)

DOI: 10.20517/and.2025.31 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ageing and Neurodegenerative Diseases, online erschienen am 06.05.2026. Verfasst von Yang Li und 3 weiteren Autor:innen. Die Arbeit nennt 319 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sporadic Parkinson’s disease (PD) is increasingly viewed as a multifactorial neurodegenerative syndrome driven by complex interactions between genetic predisposition, environmental exposures, aging-related vulnerability, and systemic dysfunctions beyond the central nervous system. Far from just a localized dopaminergic deficit, PD pathology encompasses the sensory–gut–midbrain axis and incorporates metabolic, immune, and peripheral nervous system abnormalities. This review summarizes recent advances in four dimensions. First, we highlight key genetic contributors, such as SNCA, NEAT1, and ATP13A2/PARK9, alongside environmental stressors and aging-related changes that collectively influence disease susceptibility. Second, using cross-species transcriptomic data from humans and mice, we pinpoint conserved gene networks shared across the midbrain, gut, and sensory systems. These networks include genes (PINK1, PRKN1, LRRK2, PARK7/DJ-1, SCN9A, FAAH and GCH1) involved in key pathways regulating mitochondrial quality control and oxidative stress, autophagy-mediated protein clearance, neural development and synaptic signaling, and immune-metabolic regulation, providing molecular evidence that PD manifests as a systemic network disorder. Third, we examine current and emerging therapeutic strategies, emphasizing the move from symptom relief to disease-modifying interventions through systemic, network-level, and precision approaches. Finally, we address the expanding role of early diagnostic biomarkers and computational subtyping in enabling precision-guided therapy. These insights point to future PD care relying on multidimensional strategies - combining targets co-expressed in central and peripheral neural systems, systemic regulatory modulation, and individualized care - to slow progression and ultimately prevent disease onset. This systemic and integrative perspective could shed new light on clinical and research paradigms for PD over the coming decade.

Zitieren

APA

Li, Y., Guo, L., Yu, X., & Peng, C. (2026). Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease. Ageing and Neurodegenerative Diseases, 6(2). https://doi.org/10.20517/and.2025.31

Vancouver

Li Y, Guo L, Yu X, Peng C. Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease. Ageing and Neurodegenerative Diseases. 2026;6(2). doi:10.20517/and.2025.31

BibTeX
@article{Li2026,
  author = {Li, Yang and Guo, Lijun and Yu, Xiya and Peng, Changgeng},
  title = {Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease},
  journal = {Ageing and Neurodegenerative Diseases},
  year = {2026},
  volume = {6},
  number = {2},
  doi = {10.20517/and.2025.31}
}
Kostenlos starten →